| RS150156962 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
PCNT-related disorder, PCNT-related disorder |
| RS150157112 |
L2HGDH
|
Health Risk |
Conflicting classifications of pathogenicity |
L-2-hydroxyglutaric aciduria, Inborn genetic diseases |
| RS150157202 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, CFTR-related disorder |
| RS150158100 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 16, Potassium-aggravated myotonia |
| RS150158277 |
GCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
GTP cyclohydrolase I deficiency, Dystonia 5 |
| RS150159022 |
PTPRO
|
Health Risk |
Conflicting classifications of pathogenicity |
PTPRO-related disorder, PTPRO-related disorder |
| RS150159444 |
SPTBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 5, Autosomal recessive spinocerebellar ataxia 14 |
| RS150159583 |
JAK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150159842 |
SLC52A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Brown-Vialetto-van Laere syndrome 1, Inborn genetic diseases |
| RS150161574 |
PEX13
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 11A (Zellweger), PEX13-related disorder |
| RS150161751 |
RHOXF2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150162992 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Bethlem myopathy 1A |
| RS150164316 |
LRRC8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Agammaglobulinemia 5, autosomal dominant |
| RS150165253 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS150165484 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS150166497 |
ITGB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa with pyloric atresia, Inborn genetic diseases |
| RS150166679 |
HPS4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 4, HPS4-related disorder |
| RS150167013 |
TRAPPC12
|
Health Risk |
Conflicting classifications of pathogenicity |
TRAPPC12-related disorder, TRAPPC12-related disorder |
| RS150167601 |
CNTNAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Gastric cancer |
| RS150167906 |
MIPEP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome |
| RS150168016 |
GJA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrial fibrillation, familial |
| RS150168522 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Ullrich congenital muscular dystrophy 1A |
| RS150170255 |
DNM1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150170739 |
GLI2
|
Health Risk |
Conflicting classifications of pathogenicity |
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome, Holoprosencephaly 9 |
| RS150171524 |
GLDC
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Glycine encephalopathy |
| RS150172393 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital long QT syndrome, Long QT syndrome |
| RS150174842 |
STXBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 5, Autoinflammatory syndrome |
| RS150175668 |
ABCA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Interstitial lung disease due to ABCA3 deficiency, Hereditary pulmonary alveolar proteinosis |
| RS150176097 |
GCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
GTP cyclohydrolase I deficiency, Dystonia 5 |
| RS150177278 |
BCKDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease |
| RS150177807 |
LBR
|
Health Risk |
Conflicting classifications of pathogenicity |
Greenberg dysplasia, Greenberg dysplasia |
| RS150177878 |
PSAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Sphingolipid activator protein 1 deficiency, Sphingolipid activator protein 1 deficiency |
| RS150180394 |
WRAP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal recessive 3 |
| RS150181059 |
TGM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive congenital ichthyosis 1, Autosomal recessive congenital ichthyosis 1 |
| RS150181226 |
CANT1
|
Health Risk |
Likely pathogenic |
Desbuquois dysplasia 1, Epiphyseal dysplasia |
| RS150181830 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS150182125 |
DNAI2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS150182351 |
UTP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary North American Indian childhood cirrhosis, Hereditary North American Indian childhood cirrhosis |
| RS150182714 |
COL4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome, Brain small vessel disease 1 with or without ocular anomalies |
| RS150182811 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease dominant intermediate D |
| RS150185067 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Inborn genetic diseases |
| RS150186051 |
DMXL1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150186077 |
PTCHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150186509 |
PEX12
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 3A (Zellweger), Inborn genetic diseases |
| RS150187184 |
SDHAF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pheochromocytoma and paraganglioma, Hereditary cancer-predisposing syndrome |
| RS150188026 |
HMCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 1, Age related macular degeneration 1 |
| RS150188173 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal congenital glycogen storage disease of heart, Cardiomyopathy |
| RS150188738 |
MYO18B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150189496 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
PKD1-related disorder, Polycystic kidney disease |
| RS150190277 |
PLA2G6
|
Health Risk |
Conflicting classifications of pathogenicity |
Iron accumulation in brain, Infantile neuroaxonal dystrophy |
| RS150190899 |
PEX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS150193069 |
GLDC
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycine encephalopathy, Glycine encephalopathy |
| RS150193295 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150193775 |
TJP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150194093 |
JUP
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Naxos disease |
| RS150195368 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Hereditary cancer-predisposing syndrome |
| RS150196545 |
ABCA12
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital ichthyosis of skin, ABCA12-related disorder |
| RS150197753 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS150197784 |
AMPD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia type 9, Hereditary spastic paraplegia 63 |
| RS150199251 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Duchenne muscular dystrophy |
| RS150199729 |
KIF5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 10, Hereditary spastic paraplegia 10 |
| RS150200531 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Ullrich congenital muscular dystrophy 1A |
| RS150200872 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS150200902 |
TRAPPC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal recessive 13 |
| RS150201462 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS150202288 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS150202544 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS150203483 |
SLC13A5
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 25 |
| RS150203792 |
MMP13
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150203950 |
ADAMTS10
|
Health Risk |
Conflicting classifications of pathogenicity |
Weill-Marchesani syndrome, ADAMTS10-related disorder |
| RS150205465 |
DDX41
|
Health Risk |
Conflicting classifications of pathogenicity |
DDX41-related hematologic malignancy predisposition syndrome, Inborn genetic diseases |
| RS150206751 |
TMC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 7, Autosomal dominant nonsyndromic hearing loss 36 |
| RS150207892 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS150208750 |
CHRND
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal multiple pterygium syndrome, Congenital myasthenic syndrome |
| RS150209825 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS150213016 |
LAMB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Pierson syndrome |
| RS150213018 |
GARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS150213603 |
CUL7
|
Health Risk |
Conflicting classifications of pathogenicity |
3M syndrome 1, 3M syndrome 1 |
| RS150214409 |
NDUFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leigh syndrome, Mitochondrial complex I deficiency |
| RS150215092 |
EVC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ellis-van Creveld syndrome, Inborn genetic diseases |
| RS150216454 |
FANCF
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Inborn genetic diseases |
| RS150216540 |
HPS4
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome, Hermansky-Pudlak syndrome 4 |
| RS150217523 |
MPI
|
Health Risk |
Conflicting classifications of pathogenicity |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS150218077 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS150219264 |
AUTS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150219357 |
PLCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 12 |
| RS150219690 |
IFT74
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome 40, Inborn genetic diseases |
| RS150221287 |
MCAM
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150221602 |
JAK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inherited susceptibility to asthma, Inherited susceptibility to asthma |
| RS150221689 |
ABCB6
|
Health Risk |
Conflicting classifications of pathogenicity |
Microphthalmia, isolated |
| RS150224718 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Macular degeneration |
| RS150225103 |
TCN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Transcobalamin II deficiency, TCN2-related disorder |
| RS150225347 |
ALG9
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG9 congenital disorder of glycosylation, ALG9-related disorder |
| RS150225486 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia, Spastic paraplegia |
| RS150226594 |
ARHGEF10
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant slowed nerve conduction velocity, Autosomal dominant slowed nerve conduction velocity |
| RS150226817 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Hepatocellular carcinoma |
| RS150227073 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS150227130 |
PYCR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cutis laxa, Cutis laxa |
| RS150227461 |
KIF7
|
Health Risk |
Conflicting classifications of pathogenicity |
Acrocallosal syndrome, KIF7-related disorder |
| RS150229551 |
RPS26
|
Health Risk |
Pathogenic |
— |